BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,346,934 | $56,443,763 | 54.70% |
HSG Holding Ltd | 796,089 | $19,145,940 | 2.05% |
Redmile Group, LLC | 1,469,725 | $35,346,886 | 1.68% |
ARK Investment Management | 8,783,891 | $211,252,590 | 1.62% |
Casdin Capital, LLC | 570,000 | $13,708,500 | 1.52% |
Deep Track Capital, LP | 1,015,641 | $24,426,166 | 0.94% |
Yiheng Capital Management, L.P. | 560,500 | $13,480,025 | 0.69% |
Temasek Holdings (Private) Ltd | 4,317,789 | $103,842,825 | 0.62% |
FARALLON CAPITAL MANAGEMENT LLC | 4,481,839 | $107,788,228 | 0.54% |
Alphabet Inc. | 321,604 | $7,734,576 | 0.50% |
Nikko Asset Management Americas, Inc. | 1,642,180 | $39,461,585 | 0.47% |
Green Alpha Advisors, LLC | 15,574 | $374,555 | 0.29% |
Bellevue Group AG | 694,821 | $16,710,445 | 0.27% |
Corton Capital Inc. | 20,505 | $493,145 | 0.25% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 23,500 | $564,705 | 0.19% |
Contrarius Investment Management Ltd | 126,968 | $3,054 | 0.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 4,829 | $116,137 | 0.16% |
HARBOR CAPITAL ADVISORS, INC. | 30,913 | $743,458 | 0.16% |
Clarius Group, LLC | 60,615 | $1,457,791 | 0.14% |
Woodline Partners LP | 449,732 | $10,816,055 | 0.13% |
External links
This page lists BEAM THERAPEUTICS INC's shareholders in Q3 2023. To view BEAM THERAPEUTICS INC's shareholder history, click here.